On September 11, 2026, B. Riley Securities initiated coverage of Neuronetics (NASDAQGM:STIM) with a Buy recommendation. The company’s stock closed at $3.01 on September 10, after a significant one-month price change of +38.71% from a prior close of $2.17 on August 10, 2026.
Neuronetics reported earnings on August 11, 2026, posting a revenue of $41.57 trillion, surpassing estimates of $40.98 trillion, with an actual EPS of -0.04 against an estimate of -0.125. As of September 1, 2026, analyst sentiment indicated strong support, with 9 recommendations: 3 strong buy, 5 buy, and 1 hold, resulting in an 88.9% positive rating.
The current consensus target price for Neuronetics is $6.12, suggesting an implied upside of +103.32% from its recent close, reflecting a revision from the prior target of $4.59 recorded on August 4, 2026.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
